Liposomes as versatile platform for cancer theranostics: Therapy, bio-imaging, and toxicological aspects

Swapnil Mehta, Sanjay Kulkarni, Ajinkya N. Nikam, Bharat S. Padya, Abhijeet Pandey, Srinivas Mutalik

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)

Abstract

Liposomes are nano-sized formulations having the benefits of site-specificity, biocompatibility, and biodegradability, which make them useful for the therapy and diagnosis of major diseases like cancer. In this review, various synthetic strategies of liposomes and their biomedical application in special concern to cancer are discussed. In context to the biomedical application, this article gives a detailed insight into subcellular targeted therapy and several therapeutic modifications like immunotherapy, receptor-based therapy, phototherapy, and combination therapy. The review also describes the liposome-based imaging platforms and the toxicity associated with liposomes. Owing to a significant amount of benefits of this carrier system, several products have been approved to be launched in the market and several others have already been marketed for clinical use.

Original languageEnglish
Pages (from-to)1977-1991
Number of pages15
JournalCurrent Pharmaceutical Design
Volume27
Issue number17
DOIs
Publication statusPublished - 06-2021

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Liposomes as versatile platform for cancer theranostics: Therapy, bio-imaging, and toxicological aspects'. Together they form a unique fingerprint.

Cite this